<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>81(4)</volume><submitter>Cantini F</submitter><journal>The Journal of infection</journal><pagination>647-679</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7313480</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.</pubmed_title><pmcid>PMC7313480</pmcid><pubmed_authors>Niccoli L</pubmed_authors><pubmed_authors>Sotgiu G</pubmed_authors><pubmed_authors>Navarra A</pubmed_authors><pubmed_authors>Frausini G</pubmed_authors><pubmed_authors>Lotti P</pubmed_authors><pubmed_authors>Cimolato B</pubmed_authors><pubmed_authors>Nicastri E</pubmed_authors><pubmed_authors>Landini G</pubmed_authors><pubmed_authors>Stobbione P</pubmed_authors><pubmed_authors>Cantini F</pubmed_authors><pubmed_authors>Pietro MAD</pubmed_authors><pubmed_authors>Natale MED</pubmed_authors><pubmed_authors>Aquilini D</pubmed_authors><pubmed_authors>Goletti D</pubmed_authors><pubmed_authors>Nannini C</pubmed_authors><pubmed_authors>Trezzi M</pubmed_authors><pubmed_authors>Matarrese D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2025-04-19T00:22:31.111Z</modification><creation>2025-04-07T11:25:23.594Z</creation></dates><accession>S-EPMC7313480</accession><cross_references><pubmed>32592703</pubmed><doi>10.1016/j.jinf.2020.06.052</doi></cross_references></HashMap>